Archive - May 2018
Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more
J&J pays $140m upfront for cancer-busting virus firm BeneVir
Janssen acquires BeneVir Biopharm to advance immunotherapy regimens
Bayer cuts profit guidance
Novartis’ biosimilar rituximab delayed in US
Data-driven creative agency launched
Sex Life Of Senior Americans Is Quite Active, Healthy Aging Survey Finds
5 Surprising Ways To Reduce The Risk Of Stroke
